AKARI THERAPEUTICS PLC-ADR
AKTXNASDAQ🏆 #3863 by market capEarnings Aug 18US Equity
$799.51▼ $32.38 (−4.05%)
🌙 After hours$7.73▼ 99.03%Simulated price1h—
24h▼ 4.0%
7d—
14d—
30d—
1y—
🏦Market Cap
$9M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
47
Weak
📊
Analyst Ratings
Price
$799.51
Total
8
Raised
3
Lowered
0
Avg PT
$30.00
H / L
$30 / $30
| Institution | Action | Rating | Date |
|---|---|---|---|
Maxim Group | Upgraded | Hold → Buy | 2026-07-20 |
HC Wainwright & Co. | Reiterated | Buy | 2026-04-01 |
Alliance Global Partners | Reiterated | Buy | 2022-11-01 |
B. Riley FBR | Reiterated | Buy | 2020-03-13 |
B. Riley Securities | Reiterated | Buy | 2020-03-13 |
Canaccord Genuity | Reiterated | Buy | 2018-03-29 |
William Blair | Upgraded | Market Perform → Outperform | 2017-09-22 |
Chardan Capital | Upgraded | Sell → Neutral | 2017-05-31 |
One row per institution, most recent rating